18th week of 2017 patent applcation highlights part 25 |
Patent application number | Title | Published |
20170121309 | SUBSTITUTED 2-[3-(1-METHYL-PIPERIDIN-4-YL)-PROPYLAMINO]-PYRIMIDINE-5-CARBOXYLIC ACIDS AND AMIDES AND METHODS OF MAKING THE SAME | 2017-05-04 |
20170121310 | SALTS OF A PIM KINASE INHIBITOR | 2017-05-04 |
20170121311 | CGRP RECEPTOR ANTAGONISTS | 2017-05-04 |
20170121312 | INHIBITORS OF RET | 2017-05-04 |
20170121313 | NOVEL COMPOUNDS | 2017-05-04 |
20170121314 | HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES | 2017-05-04 |
20170121315 | HETEROBICYCLICALLY SUBSTITUTED 4-OXOBUTANE ACID DERIVATIVES AND USE THEREOF | 2017-05-04 |
20170121316 | NOVEL COMPOUNDS AS DUAL INHIBITORS OF HISTONE METHYLTRANSFERASES AND DNA METHYLTRANSFERASES | 2017-05-04 |
20170121317 | METHOD FOR PRODUCING COMPOSITIONS OF FURAN GLYCIDYL ETHERS, COMPOSITIONS PRODUCED AND USES OF SAME | 2017-05-04 |
20170121318 | USE OF SMALL MOLECULE INHIBITORS TO KLF10 FOR MODULATION OF T REGULATORY CELLS AND CANCER IMMUNOTHERAPY | 2017-05-04 |
20170121319 | Herbicidal Compounds | 2017-05-04 |
20170121320 | OREXIN RECEPTOR ANTAGONISTS | 2017-05-04 |
20170121321 | Proteolysis Targeting Chimera Compounds and Methods of Preparing and Using Same | 2017-05-04 |
20170121322 | BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS | 2017-05-04 |
20170121323 | 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE DERIVATIVES AS CDK INHIBITORS AND USES THEREOF | 2017-05-04 |
20170121324 | Pyrazolo-Pyridine Derivatives as Kinase Inhibitors | 2017-05-04 |
20170121325 | FUSED IMIDAZOLE DERIVATIVES AS IDO/TDO INHIBITORS | 2017-05-04 |
20170121326 | SUBSTITUTED AROMATIC N-HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MITOGEN-ACTIVATED PROTEIN KINASE INTERACTING KINASE 1 (MNK1) AND 2 (MNK2) | 2017-05-04 |
20170121327 | JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease | 2017-05-04 |
20170121328 | DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | 2017-05-04 |
20170121329 | DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | 2017-05-04 |
20170121330 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF (R)-PRAZIQUANTEL | 2017-05-04 |
20170121331 | CGRP Receptor Antagonists | 2017-05-04 |
20170121332 | PYRIMIDINE SUBSTITUTED PURINE COMPOUNDS AS KINASE (S) INHIBITORS | 2017-05-04 |
20170121333 | COMPOSITIONS COMPRISING FOLIC ACID DERIVATIVES, THEIR PREPARATIONS AND METHODS OF USE | 2017-05-04 |
20170121334 | CRYSTALLINE FORMS OF PEMETREXED DIACID AND MANUFACTURING PROCESSES THEREFOR | 2017-05-04 |
20170121335 | NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHBITORS | 2017-05-04 |
20170121336 | IMPROVED FORMS OF A PI3K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS | 2017-05-04 |
20170121337 | Fused Bicyclic Heteroaromatic Derivatives as Kinase Inhibitors | 2017-05-04 |
20170121338 | AMINO PRYAN RING DERIVATIVE AND COMPOSITION AND USE THEREOF | 2017-05-04 |
20170121339 | PYRROLO-, PYRAZOLO-, IMIDAZO-PYRIMIDINE AND PYRIDINE COMPOUNDS THAT INHIBIT MNK1 AND MNK2 | 2017-05-04 |
20170121340 | SUBSTITUTED 2-PHENYL (AZA)BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | 2017-05-04 |
20170121341 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | 2017-05-04 |
20170121342 | HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE | 2017-05-04 |
20170121343 | Substituted Pyridine Compounds Having Herbicidal Activity | 2017-05-04 |
20170121344 | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | 2017-05-04 |
20170121345 | ANTI-FIBROTIC PYRIDINONES | 2017-05-04 |
20170121346 | ISOINDOLINE, AZAISOINDOLINE, DIHYDROINDENONE AND DIHYDROAZAINDENONE INHIBITORS OF MNK1 AND MNK2 | 2017-05-04 |
20170121347 | AMORPHOUS SOLID FORM OF A BET PROTEIN INHIBITOR | 2017-05-04 |
20170121348 | CGRP Receptor Antagonists | 2017-05-04 |
20170121349 | Anti-Infective Compounds | 2017-05-04 |
20170121350 | IMIDAZOPYRAZINE SYK INHIBITORS | 2017-05-04 |
20170121351 | Synthesis of Zinc-Lysine Complex From Zinc Chloride | 2017-05-04 |
20170121352 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | 2017-05-04 |
20170121353 | PYRAZOLE COMPOUNDS, COMPOSITIONS AND MEHTODS FOR TREATMENT OF DEGENERATIVE DISEASES AND DISORDERS | 2017-05-04 |
20170121354 | EPOXY PHOSPHONATE ESTER AS A COUPLING AGENT FOR TRANSITION METAL AND METAL OXIDE SURFACES | 2017-05-04 |
20170121355 | PROCESS FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING TWO SOLUTIONS | 2017-05-04 |
20170121356 | MOLYBDENUM SILYLCYCLOPENTADIENYL AND SILYLALLYL COMPLEXES AND USE THEREOF IN THIN FILM DEPOSITION | 2017-05-04 |
20170121357 | COMPLEXES | 2017-05-04 |
20170121358 | ALKOXIDE COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, METHOD FOR MANUFACTURING THIN FILM, AND ALCOHOL COMPOUND | 2017-05-04 |
20170121359 | PROCESS FOR SYNTHESIS OF INDENES | 2017-05-04 |
20170121360 | APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASES | 2017-05-04 |
20170121361 | Hydrolysis Resistant Sialic Acid Derivatives and Methods for Their Use | 2017-05-04 |
20170121362 | CARBOHYDRATE-BASED SURFACTANTS | 2017-05-04 |
20170121363 | Compounds, Compositions and Methods for Coloring Edible Materials | 2017-05-04 |
20170121364 | HYDROPHOBIC CERAGENIN COMPOUNDS AND DEVICES INCORPORATING SAME | 2017-05-04 |
20170121365 | SURFACE NEUTRALIZATION OF APATITE | 2017-05-04 |
20170121366 | DIPEPTIDES AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES | 2017-05-04 |
20170121367 | AGONISTS OF NEUROTROPHIN RECEPTORS AND THEIR USE AS MEDICAMENTS | 2017-05-04 |
20170121368 | NOVEL COMPOUNDS COMPRISING A BOMBESIN DERIVATIVE, A PROCESS FOR THE PREPARATION THEREOF AND A NUCLEAR MOLECULAR IMAGING AGENT COMPRISING THE SAME | 2017-05-04 |
20170121369 | INHIBITORS OF METASTASIS | 2017-05-04 |
20170121370 | ANTIBODY/DRUG CONJUGATES AND METHODS OF USE | 2017-05-04 |
20170121371 | GANIRELIX PRECURSOR AND METHOD FOR PREPARING GANIRELIX ACETATE BY USING THE SAME | 2017-05-04 |
20170121372 | NOVEL DEPSIPEPTIDE AND USES THEREOF | 2017-05-04 |
20170121373 | EXPRESSION AND CONFORMATIONAL ANALYSIS OF ENGINEERED INFLUENZA HEMAGGLUTININ | 2017-05-04 |
20170121374 | COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H1N1 INFLUENZA | 2017-05-04 |
20170121375 | CHIMERIC POLY PEPTIDES AND THE THERAPEUTIC USE THEREOF AGAINST A FLAVIVIRIDAE INFECTION | 2017-05-04 |
20170121376 | Preparation Methods for a Novel Generation of Biological Safe KLH Products Used for Cancer Treatment, for the Development of Conjugated Therapeutic Vaccines and as Challenging Agents | 2017-05-04 |
20170121377 | ARTIFICIALLY ACTIVATED TOXIC PEPTIDES | 2017-05-04 |
20170121378 | PEPTIDES HAVING EFFECTS ON PROMOTING WOUND HEALING, COLLAGEN PRODUCTION, ANGIOGENESIS, ACTIVATION OF IMMUNOCYTES AND APPLICATIONS THEREOF | 2017-05-04 |
20170121379 | USING B-CELL-TARGETING ANTIGEN IGG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES | 2017-05-04 |
20170121380 | Composition for Preventing or Treating Fatty Liver or Insulin Resistance Syndrome Including Extracellular Domain of Delta-Like 1 Homolog | 2017-05-04 |
20170121381 | PEPTIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2017-05-04 |
20170121382 | Amelioration of Chronic Kidney Disease | 2017-05-04 |
20170121383 | THERAPEUTIC USE OF BONE MORPHOGENETIC PROTEINS | 2017-05-04 |
20170121384 | ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE | 2017-05-04 |
20170121385 | METHODS OF TREATING NEURODEGENERATIVE CONDITIONS | 2017-05-04 |
20170121386 | INTEGRIN HETERODIMER AND A SUBUNIT THEREOF | 2017-05-04 |
20170121387 | METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER | 2017-05-04 |
20170121388 | FUSION PROTEINS AND USES THEREOF | 2017-05-04 |
20170121389 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | 2017-05-04 |
20170121390 | METHOD FOR NEUTRALIZING HEPATITIS C VIRUS, FULLY HUMAN MONOCLONAL ANTIBODY AGAINST HEPATITIS C VIRUS (VARIANTS), COMPOSITION OF FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HEPATITIS C VIRUS AND HYBRID MOUSE/HUMAN PRODUCER CELL LINE OF FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HEPATITIS C VIRUS (VARIANTS) | 2017-05-04 |
20170121391 | POTENT GLYCOPROTEIN ANTIBODY AS A THERAPEUTIC AGAINST EBOLA VIRUS | 2017-05-04 |
20170121392 | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EBOLA VIRUS | 2017-05-04 |
20170121393 | ANTIBODIES THAT NEUTRALIZE RSV, MPV AND PVM AND USES THEREOF | 2017-05-04 |
20170121394 | ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS | 2017-05-04 |
20170121395 | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST HUMAN IMMUNODEFICIENCY VIRUS | 2017-05-04 |
20170121396 | High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B | 2017-05-04 |
20170121397 | ANTIBODIES RECOGNIZING MEDIN | 2017-05-04 |
20170121398 | ANTI-TRANSTHYRETIN ANTIBODIES | 2017-05-04 |
20170121399 | IMPROVED IMMUNOGLOBULIN VARIABLE DOMAINS | 2017-05-04 |
20170121400 | COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH NEURODEGENERATIVE DISEASES | 2017-05-04 |
20170121401 | PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS | 2017-05-04 |
20170121402 | ORAL COMPOSITION OF ANTI-TNF ALPHA ANTIBODIES | 2017-05-04 |
20170121403 | MODULATED LYSINE VARIANT SPECIES COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME | 2017-05-04 |
20170121404 | BLOCKADE OF RGMb FOR REDUCING TRANSPLANTATION-ASSOCIATED IMMUNE RESPONSES | 2017-05-04 |
20170121405 | Methods For Treatment of Gastric Cancer | 2017-05-04 |
20170121406 | STEM CELL ENHANCING THERAPEUTICS | 2017-05-04 |
20170121407 | OXIDIZED LDL AS A BIOMARKER FOR NEUROLOGICAL COMPLICATIONS OF PREGNANCY | 2017-05-04 |
20170121408 | TREATMENT OF EOSINOPHIL OR MAST CELL RELATED DISORDERS | 2017-05-04 |